- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Gail Wilensky Remains "Hopeful" for Bipartisan Legislation on Healthcare Reform
The healthcare legislation from Senators Bill Cassidy (R-Louisiana) and Susan Collins (R-Maine) was probably the best chance at a bipartisan bill, but there are some Democrats who still seem interested in drafting bipartisan legislation, explained Gail Wilensky, PhD, of Project HOPE.
The healthcare legislation from Senators Bill Cassidy (R-Louisiana) and Susan Collins (R-Maine) was probably the best chance at a bipartisan bill, but there are some Democrats who still seem interested in drafting bipartisan legislation, explained Gail Wilensky, PhD, of Project HOPE.
Transcript
There have been rumors that some Republican senators are interested in working with Democrats to craft a healthcare bill. What do you think is the likelihood of a bipartisan bill being created?
Well, I remain ever hopeful. I find the Cassidy-Collins legislation, which is a likely vehicle to at least start discussions of bipartisan support, very promising since one of the options is if you like the Affordable Care Act you can keep the Affordable Care Act in your state with a very small haircut of 5% for the subsidies.
I was very disappointed that the Democratic leadership in the Senate just trashed that idea when it was first raised because I think it genuinely was an attempt to do outreach to Democrats to see whether they couldn’t come to an agreement on a way to allow states that like the Affordable Care Act to keep it and to allow states that wanted to use their money differently to do so within some very confined parameters.
So right now there are only about 3 Senators on the Democratic side that have expressed much interest, but we’ll see what happens in the future.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
